Literature DB >> 1846365

DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.

M Monnot1, O Mauffret, V Simon, E Lescot, B Psaume, J M Saucier, M Charra, J Belehradek, S Fermandjian.   

Abstract

Cytotoxic effects and topoisomerase II-mediated DNA breaks induced in vitro by ellipticine derivatives were examined in connection with 1H NMR and circular dichroism (CD) studies on molecular structures and interactions of drugs with DNA. The compounds included four 9-hydroxyellipticine and two 7-hydroxyisoellipticine derivatives. Structure-activity relationships indicated that a change in nitrogen atom position in the pyridinic ring greatly affected drug effects both on topoisomerase II action and cytotoxicity to L1210 cells. The four 9-hydroxyellipticine derivatives yielded bell-shaped curves in in vitro topoisomerase II-mediated DNA break assays, whereas the two 7-hydroxyisoellipticine derivatives demonstrated an almost linear increase at the same concentration (0-10 microM). In both cases, the intensity of cleavage was modulated by the position and the degree of methylation on the pyridinic ring, and results were correlated with cytotoxic activity expressed as the in vitro ID50 values for L1210 leukemia cells. 1H NMR experiments performed on free drug molecules in solution revealed that the two protons (alpha and beta) contiguous to the biologically important hydroxy group were sensitive to changes in electron distribution produced by the distant chemical modifications and methylations of the pyridinic ring. A linear relationship was observed between the differences in chemical shifts of alpha and beta protons (delta delta alpha-beta) versus ID50 values. CD experiments indicated that, at weak ionic strength I = 0.02 and at pH 7, drugs interact with the poly[d(A-T)] duplex according to a "three-mode binding model" which is governed by the drug structure and the drug to DNA ratio. The intercalation mode was related to the induction of topoisomerase II-mediated DNA cleavage, while the external binding mode consecutive to intercalation was related to cleavage suppression. These two modes concerned the good intercalators 9-hydroxyellipticines. The third was found for the weak intercalators 7-hydroxyisoellipticines and was characterized by self-stacked molecules bound "outside" DNA, presumably in the minor groove. Ligands either could be intercalated partially or linked at the edge of bases with a small number of molecules filling intercalation sites, for the second alternative. In addition to having different binding modes, 9-hydroxyellipticines were better inducers of DNA distortions than 7-hydroxyisoellipticines. The incidence of the drug binding modes on DNA-topoisomerase II recognition was discussed in connection with the in vitro cytotoxic activity exhibited by the drugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Concentration-response studies of the chromosome-damaging effects of topoisomerase II inhibitors determined in vitro using human TK6 cells.

Authors:  P Gollapudi; V S Bhat; D A Eastmond
Journal:  Mutat Res       Date:  2019-05-15       Impact factor: 2.433

2.  Cytotoxic activities and DNA binding properties of 1-methyl-7H-indeno[1,2-b]quinolinium-7-(4-dimethylamino) benzylidene triflate.

Authors:  Wen Li; Yuan Yuan Ji; Jian Wen Wang; Yong Ming Zhu
Journal:  DNA Cell Biol       Date:  2012-01-25       Impact factor: 3.311

3.  Synthesis and biological activity of 5-aza-ellipticine derivatives.

Authors:  Deborah L Moody; Marcin Dyba; Teresa Kosakowska-Cholody; Nadya I Tarasova; Christopher J Michejda
Journal:  Bioorg Med Chem Lett       Date:  2006-10-04       Impact factor: 2.823

4.  Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.

Authors:  Kendra R Vann; Yavuz Ergün; Sevil Zencir; Serkan Oncuoglu; Neil Osheroff; Zeki Topcu
Journal:  Bioorg Med Chem Lett       Date:  2016-02-15       Impact factor: 2.823

5.  Intercalative pyrimido[4',5':4,5]thieno(2,3-b)quinolines induce apoptosis in leukemic cells: a comparative study of methoxy and morpholino substitution.

Authors:  M S Shahabuddin; Mridula Nambiar; Gopal M Advirao; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2010-04-28       Impact factor: 3.850

6.  Hairpins in a DNA site for topoisomerase II studied by 1H- and 31P-NMR.

Authors:  A Amir-Aslani; O Mauffret; P Bittoun; F Sourgen; M Monnot; E Lescot; S Fermandjian
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

7.  DNA and histone deacetylases as targets for neuroblastoma treatment.

Authors:  Marie Stiborová; Jitka Poljaková; Tomáš Eckschlager; Rene Kizek; Eva Frei
Journal:  Interdiscip Toxicol       Date:  2010-06

8.  Ellipticine cytotoxicity to cancer cell lines - a comparative study.

Authors:  Marie Stiborová; Jitka Poljaková; Eva Martínková; Lucie Bořek-Dohalská; Tomáš Eckschlager; Rene Kizek; Eva Frei
Journal:  Interdiscip Toxicol       Date:  2011-06

9.  Unprocessed viral DNA could be the primary target of the HIV-1 integrase inhibitor raltegravir.

Authors:  Farah F Ammar; Safwat Abdel-Azeim; Loussinée Zargarian; Zeina Hobaika; Richard G Maroun; Serge Fermandjian
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

10.  Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.

Authors:  Yan Wu; Parisa Sadatmousavi; Rong Wang; Sheng Lu; Yong-fang Yuan; P Chen
Journal:  Int J Nanomedicine       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.